Valneva SE (VALN) Revenue Growth (3y) (2024 - 2026)
Valneva SE (VALN) Revenue Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 469.68 Bn | 464.89 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 122.76 Bn | 115.51 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 70.40 Bn | 61.65 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn | 79.44% |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 54.05% |
| 10 | Valneva SE | 833.33 Mn | 713.54 Mn | 5.38 Mn | -2.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.66% |
| Dec 31, 2025 | -29.82% |
| Sep 30, 2025 | -48.15% |
| Jun 30, 2025 | -12.19% |
| Mar 31, 2025 | 31.10% |
| Dec 31, 2024 | -43.27% |
| Sep 30, 2024 | 23.10% |
| Jun 30, 2024 | 16.15% |
| Mar 31, 2024 | 12.16% |